Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001764013-26-000058
Filing Date
2026-05-01
Accepted
2026-05-01 18:40:16
Documents
1
Period of Report
2026-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1777675214.html 4  
1 FORM 4 wk-form4_1777675214.xml 4 3918
  Complete submission text file 0001764013-26-000058.txt   5440
Mailing Address 1000 PARK FORTY PLAZA DURHAM NC 27713
Business Address 1000 PARK FORTY PLAZA DURHAM NC 27713 917-410-3120
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 151 W 42 ST 14TH FLOOR NEW YORK NY 10036
Business Address
Susman Robert Graham (Reporting) CIK: 0002065992 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38906 | Film No.: 26934195